Sublingual immunotherapy in youngsters: Adherence in a randomized clinical trial

Clinical and Experimental Allergy

Volumn 38, Issue 10, 2008, Pages 1659-1667

  Roder E ^a   Berger, M Y ^a   De Groot, H ^a   Gerth Van Wijk, R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adherence; Adolescent; Allergic rhinitis; Child; Compliance; Grass pollen; Sublingual immunotherapy

Indexed keywords

GRASS POLLEN EXTRACT; PLACEBO;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DACTYLIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HAY FEVER; HOLCUS; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PERENNIAL RYEGRASS; PHLEUM PRATENSE; POACEAE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF REPORT; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ALLERGENS; CHILD; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; PATIENT COMPLIANCE; PATIENT DROPOUTS; POACEAE; POLLEN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHINITIS, ALLERGIC, SEASONAL;

EID: 53749084651     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.03060.x     Document Type: Article

References (21)

1. Sabaté E. Editor. Adherence to long-term therapies: evidence for action. Geneva, Switzerland : World Health Organization, 2003 Available from
2. Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 1993 91 : 734 7.
3. Lower T, Henry J, Mandik L, Janosky J, Friday GA. Compliance with allergen immunotherapy. Ann Allergy 1993 70 : 480 2.
4. More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol 2002 88 : 391 4.
5. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol et Immunopathol 1990 18 : 277 84.
6. Hirsch TH, Sähn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997 8 : 21 7.
7. Vourdas D, Syrigou E, Potamianou P et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998 53 : 662 72.
8. Yuksel H, Tanac R, Gousseinov A, Demir E. Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy. Invest Allergol Clin Immunol 1999 9 : 305 13.
9. La Rosa M, Ranno C, André C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999 104 : 425 32.
10. Bahçeciler NN, Işik U, Barlan IB, Başaran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001 32 : 49 55.
11. Ippoliti F, De Santes W, Volterrani A et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003 14 : 216 21.
12. Pajno GB, Vita D, Parmiani S, Caminiti L, La Grutta S, Barberio G. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 2003 33 : 1641 7.
13. Bufe A, Ziegler-Kirbach E, Stoeckmann E et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004 59 : 498 504.
14. Rolinck-Werninghaus C, Wolf H, Liebke C et al. A prospective, randomised, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004 59 : 1285 93.
15. Valovirta E, Jacobsen L, Ljørring C, Koivikko A, Savolainen J. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006 61 : 1177 83.
16. Röder E, Berger MY, Hop WCJ, Bernsen RMD, de Groot H, Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol 2007 119 : 892 8.
17. Bousquet J, Lockey RF, Malling H-J. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998 53 (Suppl. 44) : 1 42.
18. Marogna M, Spadolini I, Massalo A, Canonica GW, Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004 59 : 1205 10.
19. Pajno GB, Vita D, Caminiti L et al. Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol 2005 116 : 1380 1.
20. Bender B, Wamboldt FS, O'Connor SL et al. Measurement of children's asthma medication adherence by self-report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000 85 : 416 21.
21. Passalacqua G, Musarra A, Pecora S et al. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year). Pediatr Allergy Immunol 2007 18 : 58 62.